Albemarle Corp buy Scotiabank
Start price
09.05.23
/
50%
€171.02
Target price
09.05.24
-
Performance (%)
-27.63%
End price
10.05.24
€123.76
Summary
This prediction ended on 10.05.24 with a price of €123.76. The prediction for Albemarle Corp disappointed with a performance of -27.63%. A total of €1.47 was paid as dividends for this prediction. Scotiabank has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Albemarle Corp | 5.723% | 5.723% | 99.052% |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% |
Comments by Scotiabank for this prediction
In the thread Albemarle Corp diskutieren
Albemarle Co. (NYSE: ALB) was upgraded by analysts at Scotiabank from a "sector perform" rating to an "outperform" rating.
Ratings data for ALB provided by MarketBeat
In the thread Trading Albemarle Corp
Die von Scotiabank gewählte maximale Laufzeit wurde überschritten